Literature DB >> 2143948

Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs.

D I Evans1, A Shaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2143948      PMCID： PMC1663310          DOI： 10.1136/bmj.300.6741.1694-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Immunogenicity of subcutaneous hepatitis B vaccine in hemophiliacs.

Authors:  R L Janco
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

2.  Use of HBV vaccine in hemophiliacs.

Authors:  C Gazengel; A M Courouce; M F Torchet; O Kremp; J Brangier; C Brechot; F Degos
Journal:  Scand J Haematol Suppl       Date:  1984

3.  Immunization of haemophiliacs against hepatitis B. A joint study between the haemophilia centers in Leuven, Belgium and Malmö, Sweden.

Authors:  U Hedner; B G Hansson; J Vermylen; M Verstraete; J Colaert; J Desmyter
Journal:  Scand J Haematol Suppl       Date:  1984

4.  Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.

Authors:  P M Mannucci; A R Zanetti; A Gringeri; E Tanzi; M Morfini; A Messori; M C Tirindelli; R de Biasi; N Ciavarella; M Colombo
Journal:  Arch Intern Med       Date:  1989-06

5.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245
  5 in total
  5 in total

1.  Hepatitis B vaccination is effective by subcutaneous route in children with bleeding disorders: a universal data collection database analysis.

Authors:  S L Carpenter; J M Soucie; R J Presley; M V Ragni; B M Wicklund; M Silvey; H Davidson
Journal:  Haemophilia       Date:  2014-11-07       Impact factor: 4.287

Review 2.  COVID-19 vaccines: Frequently asked questions and updated answers.

Authors:  M Lefebvre; N Vignier; B Pitard; E Botelho-Nevers; B Wyplosz; R Cohen; O Epaulard
Journal:  Infect Dis Now       Date:  2021-02-27

3.  Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial.

Authors:  Josep Casajuana; Begoña Iglesias; Mireia Fàbregas; Francesc Fina; Joan-Antoni Vallès; Rosa Aragonès; Mència Benítez; Edurne Zabaleta
Journal:  BMC Blood Disord       Date:  2008-05-29

4.  Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease.

Authors:  Arintaya Phrommintikul; Wanwarang Wongcharoen; Srun Kuanprasert; Narawudt Prasertwitayakij; Rungsrit Kanjanavanit; Siriluck Gunaparn; Apichard Sukonthasarn
Journal:  J Geriatr Cardiol       Date:  2014-06       Impact factor: 3.327

5.  The safety and efficacy of the tetanus vaccine intramuscularly versus subcutaneously in anticoagulated patients: a randomized clinical trial.

Authors:  Fernando I Lago-Deibe; Maria-Victoria Martín-Miguel; Carmen Velicia-Peñas; Isabel Rey Gómez-Serranillos; Manuela Fontanillo-Fontanillo
Journal:  BMC Fam Pract       Date:  2014-08-28       Impact factor: 2.497
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.